Premium

Global race on for vaccine development to tackle rare Ebola species

The Kenyan government approved the US plan to set up an Ebola quarantine facility in the country last week. President William Ruto said it was part of a long-running partnership with Washington.

This undated colorized transmission electron micrograph file image made available by the Centers for Disease Control and Prevention (CDC) shows an Ebola virus virion. (AP)This undated colorized transmission electron micrograph file image made available by the Centers for Disease Control and Prevention (CDC) shows an Ebola virus virion. (AP)
4 min readNew DelhiJun 2, 2026 04:09 PM IST First published on: Jun 2, 2026 at 03:21 PM IST

New vaccines are currently under development to tackle the Bundibugyo virus, a rare species of Ebola that is behind the latest outbreak.

One of the vaccines is being developed by the International Aids Vaccine Initiative (IAVI), while the University of Oxford and Moderna are also researching two others. There is already a vaccine for the most common Zaire species, which IAVI is attempting to modify to fight Bundibugyo.

Advertisement

Last week, Russia’s Health Minister, Mikhail Murashko, announced that Russian scientists have developed a vaccine against a new strain of Ebola that may also offer protection against Bundibugyo.

Ebola outbreak

The outbreak of Ebola, which began in the Democratic Republic of the Congo (DRC), has spread to neighbouring Uganda, infecting at least 130 people in total, according to the World Health Organization (WHO). Uganda recorded nine confirmed cases, including one death, while DRC reported 17 confirmed deaths.

Latest Comment
Post Comment
Read Comments